Catalyst Wire Dossier Catalyst Wire Dossier

Oxcarbazepine (generic)

Oxcarbazepine · Amneal Pharmaceuticals LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxcarbazepine (generic), covering 2023-03-01 to 2023-03-01. Get the full timeline:

Most recent: FDA Approved: OXCARBAZEPINE — Supplemental Application (Amneal Pharmaceuticals LLC)

See pricing